Literature DB >> 12386093

Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma.

P L Lip1, D C Felmeden, A D Blann, N Matheou, S Thakur, I A Cunliffe, G Y H Lip.   

Abstract

AIM: To investigate plasma indices of vascular permeability (vascular endothelial growth factor, VEGF-also an index of angiogenesis, as well as the soluble receptor for VEGF, sFlt-1) and endothelial damage/dysfunction (von Willebrand factor, vWf) in glaucoma.
METHODS: Citrated plasma was assayed for VEGF, sFlt-1, and vWf (all ELISA) in a cross sectional study of 50 patients (20 male; mean age 63.9 years, SD 10.5) with glaucoma: 26 had normal tension glaucoma (NTG) and 24 had primary open angle glaucoma (POAG), who were compared with 26 healthy controls (mean age 73.4 years, SD 9.2).
RESULTS: Median (interquartile range, IQR) levels of VEGF were significantly elevated in patients with NTG and POAG compared to healthy controls (Kruskal-Wallis test, p<0.001). Similarly, mean (SD) vWF levels were abnormal in NTG and POAG compared to healthy controls (one way ANOVA, p<0.001). Median levels of sFlt-1 were significantly lower in patients with NTG and POAG, when compared to healthy controls (Kruskal-Wallis test, p<0.001; p<0.05 with Tukey's post hoc test for controls v POAG). There were no significant differences in VEGF, sFlt-1 or vWf levels between the NTG and POAG groups (Tukey's test, all p=NS). In both NTG and POAG groups, there was a significant correlation between VEGF and sFlt-1 (Spearman, NTG: r=0.6517, p=0.001; POAG: r=0.6017, p=0.008). There were no significant correlations between VEGF and sFlt-1, or with vWf among the controls.
CONCLUSIONS: The pathogenesis of optic nerve damage in both NTG and POAG may be associated with abnormal vascular permeability and endothelial damage/dysfunction, as indicated by abnormal plasma VEGF and vWf levels in these patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12386093      PMCID: PMC1771371          DOI: 10.1136/bjo.86.11.1299

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  31 in total

1.  Platelet function, blood coagulability, and fibrinolysis in patients with low tension glaucoma.

Authors:  J H Joist; P Lichtenfeld; A I Mandell; A E Kolker
Journal:  Arch Ophthalmol       Date:  1976-11

2.  Peripheral endothelial dysfunction in normal pressure glaucoma.

Authors:  E Henry; D E Newby; D J Webb; C O'Brien
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-07       Impact factor: 4.799

3.  Studies of factors involved in the production of low tension glaucoma.

Authors:  S M Drance; V P Sweeney; R W Morgan; F Feldman
Journal:  Arch Ophthalmol       Date:  1973-06

4.  Circulating lipoprotein and blood glucose levels in association with low-tension and chronic simple glaucoma.

Authors:  A F Winder
Journal:  Br J Ophthalmol       Date:  1977-10       Impact factor: 4.638

5.  Systemic hypotension and glaucomatous changes.

Authors:  L M Jampol; R J Board; A E Maumenee
Journal:  Am J Ophthalmol       Date:  1978-02       Impact factor: 5.258

6.  Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.

Authors:  P L Lip; F Belgore; A D Blann; M W Hope-Ross; J M Gibson; G Y Lip
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-07       Impact factor: 4.799

7.  Viscosity and retinal vein thrombosis.

Authors:  C P Ring; T C Pearson; M D Sanders; G Wetherley-Mein
Journal:  Br J Ophthalmol       Date:  1976-06       Impact factor: 4.638

8.  Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes.

Authors:  Andrew D Blann; Funmi M Belgore; Charles N McCollum; Stanley Silverman; Peck Lin Lip; Gregory Y H Lip
Journal:  Clin Sci (Lond)       Date:  2002-02       Impact factor: 6.124

9.  Intraocular pressure, cardiovascular risk variables, and visual field defects.

Authors:  M C Leske; M J Podgor
Journal:  Am J Epidemiol       Date:  1983-08       Impact factor: 4.897

10.  Low tension glaucoma: a critical review and new material.

Authors:  R Z Levene
Journal:  Surv Ophthalmol       Date:  1980 May-Jun       Impact factor: 6.048

View more
  13 in total

1.  Biomarkers of primary open-angle glaucoma.

Authors:  Paul A Knepper; John R Samples; Beatrice Yjt Yue
Journal:  Expert Rev Ophthalmol       Date:  2010-12

2.  Higher intraocular pressure is associated with leukoaraiosis among middle-aged and elderly Koreans without glaucoma or dementia.

Authors:  B-J Park; J-K Kim; Y-J Lee
Journal:  Eye (Lond)       Date:  2014-03-28       Impact factor: 3.775

3.  Transforming growth factor beta-1 -509C>T polymorphism in Indian patients with primary open angle glaucoma.

Authors:  Sarangapani Sripriya; Ronnie George; Hemamalini Arvind; Mani Baskaran; Prema Raju; S V Ramesh; Tirumalai Karthiyayini; Lingam Vijaya; Govindasamy Kumaramanickavel
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

4.  A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Aleksander S Popel
Journal:  PLoS One       Date:  2009-04-08       Impact factor: 3.240

5.  Color Doppler imaging and pattern visual evoked potential in normal tension glaucoma and hypertension glaucoma.

Authors:  Yisheng Zhong; Yingjun Min; Ying Jiang; Yu Cheng; Jiao Qin; Xi Shen
Journal:  Doc Ophthalmol       Date:  2009-09-12       Impact factor: 2.379

6.  Retinal vein occlusions: The potential impact of a dysregulation of the retinal veins.

Authors:  Stephan A Fraenkl; Maneli Mozaffarieh; Josef Flammer
Journal:  EPMA J       Date:  2010-06-18       Impact factor: 6.543

Review 7.  A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Christopher D Kontos; Brian H Annex; Aleksander S Popel
Journal:  J Cell Mol Med       Date:  2009-10-16       Impact factor: 5.310

8.  Subconjunctival bevacizumab injection in glaucoma filtering surgery: a case control series.

Authors:  Jing Wang; Paul Harasymowycz
Journal:  ISRN Ophthalmol       Date:  2013-03-14

Review 9.  The eye and the heart.

Authors:  Josef Flammer; Katarzyna Konieczka; Rosa M Bruno; Agostino Virdis; Andreas J Flammer; Stefano Taddei
Journal:  Eur Heart J       Date:  2013-02-10       Impact factor: 29.983

10.  Levels of vascular endothelial growth factor-A165b (VEGF-A165b) are elevated in experimental glaucoma.

Authors:  Ceren Ergorul; Arjun Ray; Wei Huang; Diane Darland; Zhonghui K Luo; Cynthia L Grosskreutz
Journal:  Mol Vis       Date:  2008-08-18       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.